CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to TAK

FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin)

Phase 2
TAKEDA PHARMACEUTICAL CO LTD (TAK)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Jan '27
TAKPhase 2

FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) Phase 2 Est. Readout

FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin)
Jan 2027~
CT.gov
00%
Competitive Landscape

1 competitor in Colon Cancer

View Full Landscape
Drug Information

Target Indication

Colon Cancer

Clinical Trial

NCT07011576

Last updated: 10/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.